시장보고서

상품코드

1762298

세계의 외상성 뇌손상 바이오마커 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 샘플 유형별, 용도별, 최종 용도별, 지역별, 예측(2025-2034년)

Traumatic Brain Injury Biomarkers Market Size, Share, Trends, & Industry Analysis Report By Type (Protein Biomarkers, Genetic Biomarkers, and Metabolomic Biomarkers), By Sample Type, By Application, By End Use, and By Region - Market Forecast, 2025-2034

발행일: 2025년 06월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 125 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 외상성 뇌손상(TBI) 바이오마커 시장 규모는 2034년까지 60억 5,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 상세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

외상성 뇌손상(TBI) 바이오마커 시장은 외력에 의한 뇌손상을 평가하고 관리하는 데 도움이 되는 생물학적 지표의 개발과 활용에 초점을 맞추었습니다. 단백질 및 대사산물과 같은 신경 바이오마커 물질은 혈액, 뇌척수액, 소변과 같은 체액에서 측정됩니다. 그 목적은 TBI의 유무, 중증도, 잠재적 결과에 대한 객관적인 정보를 제공하여 초기 진단부터 장기적인 모니터링에 이르기까지 임상의가 환자 치료에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕는 것입니다.

시장 개요에 따르면 몇 가지 중요한 요인으로 인해 이러한 고급 진단 도구에 대한 수요가 증가하고 있음을 알 수 있습니다. 사고나 낙상 등 다양한 원인으로 인해 전 세계적으로 TBI 발생률이 증가함에 따라 더 나은 평가 방법에 대한 지속적인 요구가 발생하고 있습니다. 또한, 현재 진행 중인 연구와 기술 발전으로 보다 정확하고 새로운 바이오마커가 지속적으로 확인되고 있으며, 이를 보다 신속하고 쉽게 검출할 수 있게 되었습니다. 비침습적이고 빠르고 정확한 진단 솔루션에 대한 이러한 수요는 의료 서비스 제공업체들이 TBI가 상징하는 광범위한 공중보건 문제를 효율적으로 관리할 수 있는 방법을 모색하면서 시장을 크게 형성하고 있습니다.

외상성 뇌손상 바이오마커 시장 보고서 하이라이트

바이오마커 유형별로는 단백질 바이오마커가 TBI 진단에 효과적이라는 것이 입증되고, 기술 발전으로 쉽게 검출할 수 있게 되면서 2024년에는 단백질 바이오마커 분야가 가장 큰 점유율을 차지했습니다.

샘플 유형별로는 비침습적이고 쉽게 채취할 수 있으며, 응급상황에서 중요한 결과를 빠르게 얻을 수 있는 혈액 기반 바이오마커 분야가 2024년 가장 큰 점유율을 차지했습니다.

용도별로는 진단 분야가 2024년 가장 큰 점유율을 차지했습니다. 부상 시 정확한 TBI 식별이 중요하고 긴급하게 필요하기 때문입니다.

최종사용자별로는 병원 및 클리닉이 2024년 가장 큰 점유율을 차지했습니다. 병원 및 클리닉은 빠른 치료가 필요한 TBI 환자의 주요 창구이기 때문입니다.

북미는 2024년 세계 시장에서 가장 큰 점유율을 차지했습니다. 아시아태평양의 외상성 뇌손상 바이오마커 시장은 예측 기간 동안 가장 빠르게 성장할 것으로 예측됩니다.

주요 시장 기업으로는 Abbott Laboratories, Inc.(Roche Diagnostics GmbH), Bio-Rad Laboratories, Inc. Thermo Fisher Scientific Inc.,Johnson &Johnson Services, Inc. 등이 있습니다.

주요 조사 결과
서론
- 외상성 뇌손상 바이오마커 시장 분석 : 지역별, 2020년-2034년
북미
- 북미 : 유형별, 2020-2034년
- 북미 : 샘플 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 샘플 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 샘플 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 샘플 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 샘플 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제11장 기업 개요

Abbott Laboratories, Inc.
Banyan Biomarkers, Inc.
Bio-Rad Laboratories, Inc.
BrainScope Company, Inc.
DRG Diagnostics GmbH
F. Hoffmann-La Roche Ltd.(Roche Diagnostics GmbH)
Johnson & Johnson Services, Inc.
Quanterix
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

LSH 25.07.10

According to a new study by Polaris Market Research, the global traumatic brain injury (TBI) biomarkers market size is expected to reach USD 6.05 billion by 2034. The report "Traumatic Brain Injury Biomarkers Market Size, Share, Trends, & Industry Analysis Report By Type (Protein Biomarkers, Genetic Biomarkers, and Metabolomic Biomarkers), By Sample Type, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The traumatic brain injury (TBI) biomarkers market focuses on developing and using biological indicators to help assess and manage brain injuries caused by external forces. These neuro biomarker substances, such as proteins or metabolites, are measured in bodily fluids such as blood, cerebrospinal fluid, and urine. The goal is to provide objective information about the presence, severity, and potential outcomes of a TBI, supporting clinicians in making informed decisions about patient care, from initial diagnosis to long-term monitoring.

The market overview reveals a growing demand for these advanced diagnostic tools, driven by several key factors. The rising global incidence of TBIs from various causes, such as accidents and falls, creates a continuous need for better assessment methods. Moreover, ongoing research and technological advancements are constantly identifying new and more precise biomarkers, making their detection faster and more accessible. This demand for noninvasive, rapid, and accurate diagnostic solutions is significantly shaping the market, as healthcare providers seek efficient ways to manage the widespread public health challenge that TBI represents.

Traumatic Brain Injury Biomarkers Market Report Highlights:

By type, the protein biomarkers segment held the largest share in 2024 due to their established effectiveness in diagnosing TBI and technological advancements that make them easy to detect.

Based on sample type, the blood-based biomarkers segment held the largest share in 2024 as they are noninvasive and easy to collect, providing quick results crucial for emergencies.

In terms of application, the diagnosis segment held the largest share in 2024, as there is a critical and immediate need for accurate TBI identification upon injury.

By end use, the hospitals and clinics segment held the largest share in 2024 since they are the primary points of contact for TBI patients requiring immediate medical attention.

North America held the largest share in the global market in 2024. The Asia Pacific traumatic brain injury biomarkers market is projected to grow fastest during the forecast period.

A few key players in the market include Abbott Laboratories, Inc.; F. Hoffmann-La Roche Ltd. (Roche Diagnostics GmbH); Bio-Rad Laboratories, Inc.; Siemens Healthineers AG; Quanterix; Banyan Biomarkers, Inc.; Thermo Fisher Scientific Inc.; Johnson & Johnson Services, Inc.; DRG Diagnostics GmbH; and BrainScope Company, Inc.

Polaris Market Research has segmented the traumatic brain injury biomarkers market report on the basis of type, sample type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

Protein Biomarkers

Genetic Biomarkers

Metabolomic Biomarkers

By Sample Type Outlook (Revenue - USD Billion, 2020-2034)

Blood-Based

Cerebrospinal Fluid (CSF)-Based

Urine-Based

By Application Outlook (Revenue - USD Billion, 2020-2034)

Diagnosis

Prognosis

Monitoring Treatment Response

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Clinics

Diagnostic Laboratories

Research Institutes

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Traumatic Brain Injury Biomarkers Market Insights

4.1. Traumatic Brain Injury Biomarkers Market - Market Snapshot
4.2. Traumatic Brain Injury Biomarkers Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Incidence of Traumatic Brain Injuries
  - 4.2.1.2. Advancements in Biomarker Discovery and Technology
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High variability and lack of standardization
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Traumatic Brain Injury Biomarkers Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Traumatic Brain Injury Biomarkers Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
5.3. Protein Biomarkers
- 5.3.1. Global Traumatic Brain Injury Biomarkers Market, by Protein Biomarkers, by Region, 2020-2034 (USD Billion)
5.4. Genetic Biomarkers
- 5.4.1. Global Traumatic Brain Injury Biomarkers Market, by Genetic Biomarkers, by Region, 2020-2034 (USD Billion)
5.5. Metabolomic Biomarkers
- 5.5.1. Global Traumatic Brain Injury Biomarkers Market, by Metabolomic Biomarkers, by Region, 2020-2034 (USD Billion)

6. Global Traumatic Brain Injury Biomarkers Market, by Sample Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
6.3. Blood-based
- 6.3.1. Global Traumatic Brain Injury Biomarkers Market, by Blood-based, by Region, 2020-2034 (USD Billion)
6.4. Cerebrospinal fluid (CSF)-based
- 6.4.1. Global Traumatic Brain Injury Biomarkers Market, by Cerebrospinal fluid (CSF)-based, by Region, 2020-2034 (USD Billion)
6.5. Urine-based
- 6.5.1. Global Traumatic Brain Injury Biomarkers Market, by Urine-based, by Region, 2020-2034 (USD Billion)

7. Global Traumatic Brain Injury Biomarkers Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
7.3. Diagnosis
- 7.3.1. Global Traumatic Brain Injury Biomarkers Market, by Diagnosis, by Region, 2020-2034 (USD Billion)
7.4. Prognosis
- 7.4.1. Global Traumatic Brain Injury Biomarkers Market, by Prognosis, by Region, 2020-2034 (USD Billion)
7.5. Monitoring treatment response
- 7.5.1. Global Traumatic Brain Injury Biomarkers Market, by Monitoring treatment response, by Region, 2020-2034 (USD Billion)

8. Global Traumatic Brain Injury Biomarkers Market, by End Use

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
8.3. Hospitals & Clinics
- 8.3.1. Global Traumatic Brain Injury Biomarkers Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
8.4. Diagnostic Laboratories
- 8.4.1. Global Traumatic Brain Injury Biomarkers Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
8.5. Research Institutes
- 8.5.1. Global Traumatic Brain Injury Biomarkers Market, by Research Institutes, by Region, 2020-2034 (USD Billion)

9. Global Traumatic Brain Injury Biomarkers Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Traumatic Brain Injury Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Traumatic Brain Injury Biomarkers Market - North America
- 9.3.1. North America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
- 9.3.3. North America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 9.3.4. North America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5. Traumatic Brain Injury Biomarkers Market - US
  - 9.3.5.1. US: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6. Traumatic Brain Injury Biomarkers Market - Canada
  - 9.3.6.1. Canada: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
9.4. Traumatic Brain Injury Biomarkers Market - Europe
- 9.4.1. Europe: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
- 9.4.3. Europe: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 9.4.4. Europe: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5. Traumatic Brain Injury Biomarkers Market - UK
  - 9.4.5.1. UK: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6. Traumatic Brain Injury Biomarkers Market - France
  - 9.4.6.1. France: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7. Traumatic Brain Injury Biomarkers Market - Germany
  - 9.4.7.1. Germany: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8. Traumatic Brain Injury Biomarkers Market - Italy
  - 9.4.8.1. Italy: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9. Traumatic Brain Injury Biomarkers Market - Spain
  - 9.4.9.1. Spain: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10. Traumatic Brain Injury Biomarkers Market - Netherlands
  - 9.4.10.1. Netherlands: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11. Traumatic Brain Injury Biomarkers Market - Russia
  - 9.4.11.1. Russia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12. Traumatic Brain Injury Biomarkers Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
9.5. Traumatic Brain Injury Biomarkers Market - Asia Pacific
- 9.5.1. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5. Traumatic Brain Injury Biomarkers Market - China
  - 9.5.5.1. China: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6. Traumatic Brain Injury Biomarkers Market - India
  - 9.5.6.1. India: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7. Traumatic Brain Injury Biomarkers Market - Malaysia
  - 9.5.7.1. Malaysia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8. Traumatic Brain Injury Biomarkers Market - Japan
  - 9.5.8.1. Japan: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9. Traumatic Brain Injury Biomarkers Market - Indonesia
  - 9.5.9.1. Indonesia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10. Traumatic Brain Injury Biomarkers Market - South Korea
  - 9.5.10.1. South Korea: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11. Traumatic Brain Injury Biomarkers Market - Australia
  - 9.5.11.1. Australia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12. Traumatic Brain Injury Biomarkers Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
9.6. Traumatic Brain Injury Biomarkers Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5. Traumatic Brain Injury Biomarkers Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6. Traumatic Brain Injury Biomarkers Market - UAE
  - 9.6.6.1. UAE: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7. Traumatic Brain Injury Biomarkers Market - Israel
  - 9.6.7.1. Israel: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8. Traumatic Brain Injury Biomarkers Market - South Africa
  - 9.6.8.1. South Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9. Traumatic Brain Injury Biomarkers Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
9.7. Traumatic Brain Injury Biomarkers Market - Latin America
- 9.7.1. Latin America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5. Traumatic Brain Injury Biomarkers Market - Mexico
  - 9.7.5.1. Mexico: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6. Traumatic Brain Injury Biomarkers Market - Brazil
  - 9.7.6.1. Brazil: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7. Traumatic Brain Injury Biomarkers Market - Argentina
  - 9.7.7.1. Argentina: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8. Traumatic Brain Injury Biomarkers Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott Laboratories, Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Banyan Biomarkers, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bio-Rad Laboratories, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. BrainScope Company, Inc.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. DRG Diagnostics GmbH
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. F. Hoffmann-La Roche Ltd. (Roche Diagnostics GmbH)
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Johnson & Johnson Services, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Quanterix
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Siemens Healthineers AG
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Thermo Fisher Scientific Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development

세계의 외상성 뇌손상 바이오마커 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 샘플 유형별, 용도별, 최종 용도별, 지역별, 예측(2025-2034년)

Traumatic Brain Injury Biomarkers Market Size, Share, Trends, & Industry Analysis Report By Type (Protein Biomarkers, Genetic Biomarkers, and Metabolomic Biomarkers), By Sample Type, By Application, By End Use, and By Region - Market Forecast, 2025-2034

외상성 뇌손상 바이오마커 시장 보고서 하이라이트

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 외상성 뇌손상 바이오마커 시장 인사이트

제5장 세계의 외상성 뇌손상 바이오마커 시장 : 유형별

제6장 세계의 외상성 뇌손상 바이오마커 시장 : 샘플 유형별

제7장 세계의 외상성 뇌손상 바이오마커 시장 : 용도별

제8장 세계의 외상성 뇌손상 바이오마커 시장 : 최종 용도별

제9장 세계의 외상성 뇌손상 바이오마커 시장 : 지역별